378
Views
4
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Drug safety evaluation of olanzapine pamoate

, &
Pages 897-903 | Published online: 12 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ernie Anand, Lovisa Berggren, John Landry, Ágoston Tóth & Holland C Detke. (2016) Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being. Neuropsychiatric Disease and Treatment 12, pages 2737-2743.
Read now
Ludovic Samalin, Ricardo Garay, Ahcène Ameg & Pierre-Michel Llorca. (2016) Olanzapine pamoate for the treatment of schizophrenia – a safety evaluation. Expert Opinion on Drug Safety 15:3, pages 403-411.
Read now

Articles from other publishers (2)

Varun Jaitpal & Sushil Gawande. (2022) Olanzapine-Induced Parkinsonism and Akathisia: A Case Report. Cureus.
Crossref
Daniel Luedecke, Daniel Schöttle, Anne Karow, Martin Lambert & Dieter Naber. (2014) Post-Injection Delirium/Sedation Syndrome in Patients Treated with Olanzapine Pamoate: Mechanism, Incidence, and Management. CNS Drugs 29:1, pages 41-46.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.